Sun.Mar 03, 2024

article thumbnail

Role of Qufeng Tongqiao Prescription in the protection of cerebral ischemia and associated molecular network mechanism

Chemical Biology and Drug Design

Study on the mechanism of graph Qufeng Tongqiao Prescription in the treatment of cerebral ischemia through network pharmacology combined with animal experiments. Abstract To explore the of Qufeng Tongqiao Prescription in the treatment of cerebral ischemia–reperfusion (CIR) and associated molecular network mechanism. Venny diagram, gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG) analysis, protein–protein interaction (PPI), hub genes mining, molecular docking, combined with a

Treatment 100
article thumbnail

Keeping Your Company’s Federal Contracting Options Safe in the Face of Pending BIOSECURE Act Legislation

FDA Law Blog: Biosimilars

By Steven J. Gonzalez & JP Ellison — The most recent version of the BIOSECURE Act (the “Act”) was introduced in the U.S. House of Representatives ( H.B. 7085 ) and Senate ( S.B. 3558 ) on January 25, 2024. This proposed legislation should be of interest to any biotechnology companies that want to do business with the federal government in the future.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Ukraine?

Drug Patent Watch

This chart shows the drugs with the most patents in Ukraine. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Ukraine? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

The LDT Rule Takes Another Step to Finalization — and a Likely Lawsuit

FDA Law Blog: Biosimilars

By Jeffrey N. Gibbs & Allyson B. Mullen — FDA’s proposed rule to regulate laboratory developed tests (LDTs) as devices took one more step towards being finalized – and to a likely judicial showdown. On March 1, the Office of Management and Budget (OMB) received the draft final LDT rule for review ( here ). The LDT rule has moved forward with astonishing speed, advancing from the release of the proposed rule on October 3, 2023 to OMB in less than five months.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Stories We’d Like to Publish

Codon

Alexander von Humboldt relaxes in his library. Looks like a nice place! Asimov Press has now existed for two months. ( Woo! ) We’re publishing an essay at a pace of roughly one per week, and our first printed compilation will be available in May. But there are only two of us (Niko & Xander), and our pile of essay ideas has already swelled to 450+ rows in a spreadsheet.

DNA 79